179 related articles for article (PubMed ID: 12435517)
21. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
Enright AM; Prober C
Herpes; 2003 Aug; 10(2):32-7. PubMed ID: 14577952
[TBL] [Abstract][Full Text] [Related]
22. Retinoids: unapproved uses or indications.
Arechalde A; Saurat JH
Clin Dermatol; 2000; 18(1):63-76. PubMed ID: 10701087
[No Abstract] [Full Text] [Related]
23. Drugs for non-HIV viral infections.
Treat Guidel Med Lett; 2010 Oct; 8(98):71-82; quiz 2 p following 82. PubMed ID: 20864902
[No Abstract] [Full Text] [Related]
24. Mixed results from combination therapy.
Griffiths PD
Rev Med Virol; 2011 Nov; 21(6):333-5. PubMed ID: 22025361
[No Abstract] [Full Text] [Related]
25. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
Ostroff C; Lee CE; McMeekin J
Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
[TBL] [Abstract][Full Text] [Related]
26. Tigecycline (Tygacil).
Obstet Gynecol; 2006 Jan; 107(1):178-80. PubMed ID: 16394058
[No Abstract] [Full Text] [Related]
27. NDA filed to treat refractory herpes.
AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361756
[No Abstract] [Full Text] [Related]
28. Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials.
Shepshelovich D; Tibau A; Goldvaser H; Molto C; Ocana A; Seruga B; Amir E
J Clin Oncol; 2018 Jun; 36(18):1798-1804. PubMed ID: 29641296
[TBL] [Abstract][Full Text] [Related]
29. An EUA for casirivimab and imdevimab for COVID-19.
Med Lett Drugs Ther; 2020 Dec; 62(1614):201-202. PubMed ID: 33451174
[No Abstract] [Full Text] [Related]
30. Antihelmintic and antiparasitic drugs: unapproved uses or indications.
Goihman-Yahr M
Clin Dermatol; 2000; 18(1):113-7. PubMed ID: 10701092
[No Abstract] [Full Text] [Related]
31. [Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
Pi Sala N; Figueras Suriol A; Ramió Montero E
Farm Hosp; 2017 Jan; 41(n01):132-133. PubMed ID: 28045657
[No Abstract] [Full Text] [Related]
32. Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval.
Naci H; Wouters OJ; Gupta R; Ioannidis JPA
Milbank Q; 2017 Jun; 95(2):261-290. PubMed ID: 28589600
[TBL] [Abstract][Full Text] [Related]
33. Drugs for non-HIV viral infections.
Treat Guidel Med Lett; 2007 Jul; 5(59):59-70. PubMed ID: 17565338
[No Abstract] [Full Text] [Related]
34. Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
O'Reilly J; Dalal A
Ann Health Law; 2003; 12(2):295-324, table of contents. PubMed ID: 12856461
[TBL] [Abstract][Full Text] [Related]
35. FDA targets unapproved drugs.
Young D
Am J Health Syst Pharm; 2007 Feb; 64(4):347-8. PubMed ID: 17299170
[No Abstract] [Full Text] [Related]
36. Full-day ADHD symptom control that "lasts from home to homework".
Pediatr Nurs; 2000; 26(6):634-5. PubMed ID: 12026370
[No Abstract] [Full Text] [Related]
37. In brief: severe bradycardia with sofosbuvir and amiodarone.
Med Lett Drugs Ther; 2015 Apr; 57(1466):58. PubMed ID: 25853664
[No Abstract] [Full Text] [Related]
38. FDA notifications. FDA revises Baraclude labeling for HIV patients.
AIDS Alert; 2007 Sep; 22(9):103-4. PubMed ID: 18415955
[No Abstract] [Full Text] [Related]
39. Immunosuppressant and cytotoxic drugs: unapproved uses or indications.
Abel EA
Clin Dermatol; 2000; 18(1):95-101. PubMed ID: 10701090
[No Abstract] [Full Text] [Related]
40. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
